We first investigated vaccine-induced CD8+ T-cell responses in B16F10 tumor-bearing mice treated with anti-PD1, DLnano_LS_Trp2188 (Trp2Vax) and TA99-WT versus TA99-HL2-KOA1. The gene discussed is CD8A; the disease is neoplasm.